Next Article in Journal
Sodium Chloride Induced Stress Responses of Antioxidative Activities in Leaves and Roots of Pistachio Rootstock
Next Article in Special Issue
Dual Role for Astroglial Copper-Assisted Polyamine Metabolism during Intense Network Activity
Previous Article in Journal
Circular RNA Expression Profiles in Plasma from Patients with Heart Failure Related to Platelet Activity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 10
Issue 2
10.3390/biom10020188
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BKCa-Channel Activity and Inhibits IK(M) or Ih

by
Te-Ling Lu
1,
Zi-Han Gao
2,
Shih-Wei Li
2 and
Sheng-Nan Wu
2,3,4,*
1
School of Pharmacy, China Medical University, Taichung City 40402, Taiwan
2
Department of Physiology, National Cheng Kung University Medical College, Tainan City 70101, Taiwan
3
Institute of Basic Medical Sciences, National Cheng Kung University Medical College, Tainan City 70701, Taiwan
4
Department of Medical Research, China Medical University Hospital, China Medical University, Taichung City 40402, Taiwan
*
Author to whom correspondence should be addressed.
Biomolecules 2020, 10(2), 188; https://doi.org/10.3390/biom10020188
Submission received: 27 December 2019 / Revised: 20 January 2020 / Accepted: 21 January 2020 / Published: 25 January 2020
(This article belongs to the Special Issue Polyamines in the Central Nervous System: Neurons, Glial Cells and Diseases)
Browse Figures
Review Reports Versions Notes

Abstract

:
GAL-021 has recently been developed as a novel breathing control modulator. However, modifications of ionic currents produced by this agent remain uncertain, although its efficacy in suppressing the activity of big-conductance Ca2+-activated K+ (BKCa) channels has been reported. In pituitary tumor (GH3) cells, we found that the presence of GAL-021 decreased the amplitude of macroscopic Ca2+-activated K+ current (IK(Ca)) in a concentration-dependent manner with an effective IC50 of 2.33 μM. GAL-021-mediated reduction of IK(Ca) was reversed by subsequent application of verteporfin or ionomycin; however, it was not by that of diazoxide. In inside-out current recordings, the addition of GAL-021 to the bath markedly decreased the open-state probability of BKCa channels. This agent also resulted in a rightward shift in voltage dependence of the activation curve of BKCa channels; however, neither the gating charge of the curve nor single-channel conductance of the channel was changed. There was an evident lengthening of the mean closed time of BKCa channels in the presence of GAL-021, with no change in mean open time. The GAL-021 addition also suppressed M-type K+ current with an effective IC50 of 3.75 μM; however, its presence did not alter the amplitude of erg-mediated K+ current, or mildly suppressed delayed-rectifier K+ current. GAL-021 at a concentration of 30 μM could also suppress hyperpolarization-activated cationic current. In HEK293T cells expressing α-hSlo, the addition of GAL-021 was also able to suppress the BKCa-channel open probabilities, and GAL-021-mediated suppression of BKCa-channel activity was attenuated by further addition of BMS-191011. Collectively, the GAL-021 effects presented herein do not exclusively act on BKCa channels and these modifications on ionic currents exert significant influence on the functional activities of electrically excitable cells occurring in vivo.

1. Introduction

GAL-021 has recently been developed as a novel breathing control modulator thought to preserve respiratory drive and to protect patients from the respiratory impairment resulting from opioids and other modalities; moreover, it notably did not influence analgesia [1,2,3,4,5,6,7]. The studies have also reported that this agent is an experimental drug demonstrated to inhibit Ca2+-activated K+ channels with big conductance functionally expressed on type 1 cells of the carotid bodies [1,8,9]. However, to what extent this compound perturbs other patterns of voltage-gated ionic currents has not yet been determined.
The big-conductance Ca2+-activated K+ (BKCa) channels (KCa1.1, KCNMA1, Slo1), belonging to family of voltage-activated K+ channels, are stimulated by increasing Ca2+ concentrations in the cell and by membrane depolarization, and the channel activation of their own accord can then conduct large amounts of potassium ions (K+) across the cell membrane. Because of the large conductance, BKCa channel is also known as maxi- or big-K channel. BKCa channels, which are functionally expressed in a variety of cells, can play substantial roles in physiological and pathophysiological events including neurotransmitter release, muscle relaxation, and oxygen sensing in chemoreceptor cells [1,8,10,11,12,13,14,15,16,17,18,19]. It is also noted that BMS-204352 (MaxiPostTM), an activator of BKCa channels, could activate a voltage-independent KCNQ4-encoded current [20,21].
The KCNQ gene family encodes five Kv7 K+ channel subunits. The KCNQ2, KCNQ3, and KCNQ5 genes encode the core subunits of Kv7.2, Kv7.3, and Kv7.5 channels, respectively, expressed in the nervous system. They are the principal molecular components of the voltage-gated M-type currents (IK(M)), the magnitude of which can widely regulate neuronal excitability. Once activated, they are characterized by a slow activating and deactivating property [22,23,24,25]. KCNQ2 and KCNQ3 were noted to be mutated in patients with benign familial neonatal convulsions (BFNC). This implies that the activity of M-type (or KCNQx) channels can assist in controlling seizure discharges. Pharmacological targeting of IK(M) can be as an adjunctive therapy for various neurological disorders associated with neuronal over-excitability, such as cognitive dysfunction, neuropathic pain, and epilepsy [23,26,27].
Hyperpolarization-activated cationic current (Ih or funny current [If]) is inwardly directed when activated, and therefore increased magnitude of the current depolarizes the membrane potential. Ih contributes repetitive electrical activity in various types of electrically excitable cells, such as heart cells, neuroendocrine or endocrine cells, or central neurons [28,29,30,31]. This type of current is carried by Na+ and K+ ions under normal physiological conditions, and the activation of its own accord, then, depolarizes membrane potential, whereby it readily leads the resting potential of the cell to reach the threshold required for action potential generation. The Ih channels are encoded by the hyperpolarization-activated cyclic nucleotide-gated (HCN) gene family. The HCN gene belongs to the superfamily of voltage-gated K+ channels and so far, four HCN channel isoforms (i.e., HCN1-4) exist. Active respiratory neurons were previously reported to functionally express HCN channels [32,33,34]. However, little information is available regarding the underlying mechanism of actions of GAL-021 or other related compounds on different types of ionic currents (e.g., IK(M) and Ih) present in endocrine or neuroendocrine cells, or central mammalian neurons, although it was previously reported to suppress the activity of BKCa channels in type 1 cells of the carotid bodies [1]. Therefore, in this study, we wanted to investigate the ionic mechanisms by which the presence of GAL-021 is able to interact functionally with ion channels, thereby producing any clear modifications on macroscopic ionic currents identified in pituitary GH3 cells. Macroscopic or microscopic ionic currents studied include Ca2+-activated K+ current (IK(Ca)), BKCa channels, IK(M), Ih, erg-mediated K+ current (IK(erg)), and delayed-rectifier K+ current (IK(DR)). Suppressive effects of GAL-021 on α-hSlo expressing HEK293T renal epithelial cells were also tested in this study. The findings from these results are useful as they highlight potential mechanisms of ionic action of GAL-021 or related compounds in electrically excitable cells, if similar in vivo observations occur.

2. Materials and Methods

2.1. Chemicals, Drugs, and Solutions

For this study, GAL-021 (N2-methoxy-N2-methyl-N4,N6-dipropyl-1,3,5-triazine-2,4,6-triamine or N-[4,6-bis-n-propylamino-(1,3,5)-triazin-2-yl]-N,O-dimethylhydroxyamine, C11H22N6O) was acquired from MedChemExpress (Everything Biotech, New Taipei City, Taiwan). Flupirtine, ionomycin, 9-phenanthrol, tetrodotoxin, and verteporfin were obtained from Sigma-Aldrich (Merck Ltd., Taipei, Taiwan), BMS-191011, telmisartan, and XE991 were obtained from Tocris (Union Biomed Inc., Taipei City, Taiwan), and dexmedetomidine was from Abbott Laboratories (Taipei City, Taiwan). For cell preparations, all culture media, fetal calf serum, horse serum, l-glutamine, and trypsin/EDTA were acquired from HyCloneTM (Thermo Fisher Scientific, Logan, UT), unless stated otherwise, while all other chemicals such as CdCl2, EGTA, HEPES, and aspartic acid, were commercially and of reagent grade. In the experiments, we used the twice-distilled water that had been de-ionized through a Millipore-Q system.
The composition of bath solution for GH3 cells, that is, normal Tyrode’s solution buffered by HEPES, was as follows (in mM): NaCl 136.5, KCl 5.4, CaCl2 1.8, MgCl2 0.53, glucose 5.5, and HEPES 5.5 titrated to pH 7.4 with NaOH. To measure macroscopic K+ currents (i.e., IK(Ca), IK(M), or IK(DR)), we filled the patch pipette with a solution (in mM): KCl 140, MgCl2 1, Na2ATP 3, Na2GTP 0.1, EGTA 0.1, and HEPES 5 titrated to pH 7.2 with KOH. To measure BKCa-channel activity under the inside-out patch configuration, the bath solution contained a high K+ solution (in mM): KCl 130, NaCl 10, MgCl2 3, glucose 6, and HEPES-KOH buffer 10 titrated to pH 7.4 with KOH, while the pipette solution contained (in mM): KCl 145, MgCl2 2, and HEPES 5 titrated to 7.4 with KOH. The value of free Ca2+ concentration was assessed, assuming that there was a dissociation constant of 0.1 μM for EGTA and Ca2+ (at pH 7.2). For example, to provide 0.1 μM Ca2+ in the bathing solution, 1 mM EGTA and 0.5 mM CaCl2 were added. We commonly filtered the pipette solutions and culture media on the day of use with Acrodisc® syringe filter with 0.2 mm Super® membrane (Bio-Check Lab., Pall Corp., Taipei City, Taiwan).

2.2. Cell Preparations

GH3 pituitary tumor cells, acquired from the Bioresources Collection and Research Center ([BCRC-60015]; Hsinchu, Taiwan), were maintained in Ham’s F-12 media supplemented with 15% horse serum (v/v), 2.5% fetal calf serum (v/v), and 2 mM L-glutamine (Wu et al., 2017). To facilitate cell differentiation, cells were transferred to a serum-free, Ca2+-free medium. Under our experimental conditions, cells remained 80% to 90% viable for at least two weeks. The HEK293T cell line was obtained from American Type Culture Collection (CRL-11268; Union Biomed Inc., Taipei City, Taiwan). Cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 2 mM l-glutamine and 10% fetal bovine serum (v/v). Cells were maintained at 37 °C in a humidified environment of 5% CO2 and 95% air incubator.

2.3. Transfection

The pCMV6-XL4 vector containing human BKCa-channel pore-forming α-subunit cDNA (α-hSlo; NM_002247.1) was obtained from OriGeneTM Technologies (Level Biotechnology, Kaohsiung City, Taiwan). The α-hSlo gene was recognized to encode a functional BKCa channel. We transfected the expression plasmid into HEK293T cells for transient expression. Briefly, the expression plasmid was prepared in 150 mM NaCl as a diluent solution. We mixed polyethylenimine (PEI) (ExGen 500; MBI Fermentas, Hanover, MD, USA) and plasmid together and, then, incubated them for 10 min at room temperature for sufficient binding of the plasmid to PEI. We, then, added plasmid-PEI mixture solution to the 24-well plate and centrifuged it at 280× g for 5 min. After centrifugation, transfected cells were incubated at 37 °C for an additional 48 h.

2.4. Electrophysiological Measurements

Shortly before the measurements, cells (e.g., GH3 or HEK293T cells) were harvested and transferred to a homemade recording chamber positioned on the fixed stage of an inverted Olympus fluorescent microscope (CKX-41; Yuan Yu, Taipei City, Taiwan). Cells were put into in normal Tyrode’s solution at room temperature (22 to 25 °C). After cells were left to adhere to the bottom for several minutes, the recordings were performed. Patch-clamp experiments under either whole-cell, cell-attached, or inside-out mode were achieved with either an RK-400 (Biologic, Claix, France) or an Axopatch-200B amplifier (Molecular Devices, Sunnyvale, CA) [16,35]. We fabricated patch pipettes, the resistance of which was around 3 to 5 MΩ, from Kimax-51 borosilicate capillaries (#34500; Kimble; Dogger, New Taipei City, Taiwan) pulled on either a PP-830 vertical puller (Narishige, Major Instruments, New Taipei City, Taiwan) or a P-97 programmable horizontal puller (Sutter Instruments, Novato, CA, USA), and the pipettes were then fire polished with an MF-83 microforge (Narishige). During measurements, the digitized signals, consisting of voltage and current tracings, were stored online at 10 kHz in an ASUSPRO-BU401LG computer (ASUS, New Taipei City, Taiwan) controlled by pCLAMP 10.7 software (Molecular Devices).

2.5. Data Analyses

To assess concentration-dependent inhibition of GAL-021 on the amplitude of IK(Ca) or IK(M), cells were bathed in normal Tyrode’s or high-K+, Ca2+-free solution, respectively. For studying IK(Ca), each cell examined was maintained at 0 mV and 300 ms voltage step from 0 to +50 mV was delivered, whereas for IK(M), we held at the level of −50 mV and the depolarizing pulse to −10 mV with 1 sec duration was applied. Current amplitudes measured at +50 mV (IK(Ca)) or −10 mV (IK(M)) in response to depolarizing pulses were taken in the control and during the exposure to different concentrations (0.1 to 30 μM) of GAL-021. The concentration required to suppress 50% of IK(Ca) or IK(M) amplitude was achieved by use a modified form of the Hill equation:
Relative   amplitude = [ G A L ] − n H × ( 1 − a ) [ G A L ] − n H + I C 50 − n H + a
where [GAL] represents the different concentrations of GAL-021; nH and IC50 are the Hill coefficient and the concentration required for a 50% inhibition of IK(Ca) or IK(M) amplitude, respectively. Maximal inhibition (i.e., 1-a) of IK(Ca) or IK(M) was also assessed from this equation.

2.6. Single Channel Recordings

Unitary BKCa-channel currents were recorded and then analyzed by pCLAMP 10.7 (Molecular Devices). We implemented multi-Gaussian adjustments of the amplitude distributions among channels, in attempts to evaluate the opening events of single-channel currents. Functional independence between channels was verified by comparing the observed stationary probabilities with the values calculated according to the binomial law. The open-state probabilities of the channels were expressed as N⋅PO which can be evaluated by use of the following form:
N · P O = A 1 + 2 A 2 + 3 A 3 + … + n A n A 0 + A 1 + A 2 + A 3 + … + A n
where N is the number of active channels in the patch examined, A0 is the area under the curve of an all-points histogram corresponding to the resting (or closed) state, and A1 to An are the histogram areas reflecting the levels of distinct open state for 1 to n channels residing in the patch.
To determine the effects of GAL-021 on the activation curve of BKCa channels, the upsloping ramp pulses from +20 to +120 mV with a duration of 1 sec were designed and created from pCLAMP 10.7, and, then, they were applied to the membrane patch. The activation curve elicited during ramp pulses were calculated by averaging current traces in response to 20 voltage ramps and dividing each point of mean current by single-channel amplitude of each potential when the leakage component was corrected. The activation curves of the channel taken with or without GAL-021 addition were least-squares fitted with a modified Boltzmann function:
relative   open   probability = n P 1 + e x p [ − ( V − V 1 2 ) q F R T ]
where nP is the maximal open probability of BKCa-channel openings in the control at the level of +120 mV; V1/2 is the voltage at which there is half-maximal activation of the channel; q is the apparent gating charge; and F, R or T indicates Faraday’s constant, the universal gas constant, or the absolute temperature, respectively.

2.7. Statistical Analyses

To assess linear or nonlinear (e.g., sigmoidal or exponential) curve fitting to the dataset was utilized by using OriginPro (OriginLab; Scientific Formosa, Taipei, Taiwan). The experimental results obtained were analyzed and, then, plotted using OriginPro (OriginLab). They were expressed as mean ± standard error of the mean of (SEM). We used the paired or unpaired Student’s t-test, or one-way analysis of variance (ANOVA) followed by Bonferroni’s post-hoc test for multiple comparisons, for statistical evaluation of differences among mean values. We used Kruskal–Wallis nonparametric test, if there was possible violation with respect to the assumption of normality underlying ANOVA. p Value <0.05 was considered significant, unless stated otherwise.

3. Results

3.1. Inhibitory Effect of GAL-021 on Ca2+-Activated K+ Current (IK(Ca)) Amplitude Measured from Pituitary GH3 Lactotrophs

In an initial stage of electrophysiological recordings, we performed the whole cell configuration of patch-clamp experiments, in order to assess any possible perturbations of GAL-021 on IK(Ca) amplitude identified in these cells. The voltage-clamp current recordings were conducted in cells bathed in HEPES-buffered normal Tyrode’s solution into which 1.8 mM CaCl2 was put, and the recording pipette was filled with K+-containing solution which contained 140 mM K+, 0.1 mM EGTA, and 3 mM ATP. As whole-cell model, that is, when membrane patch was broken by suction, was achieved, we maintained the examined cell at the level of 0 mV, a level which was delivered to inactivate other types of outwardly rectifying K+ currents [36], and ionic currents were then evoked by a series of voltage pulses ranging between 0 and +80 mV. This type of macroscopic outward currents with a markedly noisy and outwardly rectifying property has been regarded as IK(Ca) which is particularly subject to inhibition by tremorgenic mycotoxins (e.g., paxilline or verroculogen) [16,35,37]. As illustrated in Figure 1A,B, the presence of GAL-021 (1 or 3 μM) produced a progressive decrease in IK(Ca) amplitude measured at the entire voltage-clamp steps. For example, at the level of +60 mV, the presence of 3 μM GAL-021 was able to decrease IK(Ca) amplitude from 418 ± 36 to 124 ± 13 pA (n = 8 and p < 0.05). After washout of the compound, current amplitude returned to 372 ± 24 pA (n = 7 p < 0.05). Similarly, as the cells were exposed to GAL-021 (3 μM), the whole-cell (i.e., macroscopic) conductance of IK(Ca) measured at the voltages ranging between +40 and +80 mV was significantly decreased to 3.41 ± 0.12 nS from a control value of 5.03 ± 0.18 nS (n = 7 and p < 0.05).
Concentration-dependent relation of GAL-021-mediated suppression of IK(Ca) was further analyzed. As shown in Figure 1C, the relationship between the GAL-021 concentrations and the relative amplitude of IK(Ca) was constructed. Notably, this compound could effectively suppress the amplitude of IK(Ca) in a concentration-dependent fashion. On the basis of a least-squares fit to the modified Hill equation, the results yielded a concentration required for half-maximal inhibition of 2.33 μM (i.e., IC50) and a Hill coefficient of 1.2.

3.2. Comparison of the Effect of GAL-021 on IK(Ca) in the Absence and Presence of Diazoxide, Verteporfin, or Ionomycin

We further tested whether the suppressive effect of GAL-021 on IK(Ca) was perturbed by diazoxide, a stimulator of ATP-sensitive K+ (KATP) channels [38]; verteporfin, an activator of IK(Ca) [35]; or ionomycin, a Ca2+ ionophore [39]. As shown in Figure 2, when the cells were depolarized from 0 to +50 mV, exposure to GAL-021 (3 μM) significantly suppressed the amplitude of IK(Ca). However, further application of diazoxide (10 μM), still in the presence of GAL-021, did not attenuate its amplitude significantly. Conversely, subsequent addition of either verteportin (10 μ M) or ionomycin (10 μM) was found to reverse the IK(Ca) amplitude induced by the presence of GAL-021 alone (Figure 2). For example, there was a notable difference in IK(Ca) amplitude between GAL-021 (3 μM) alone and GAL-021 (3 μM) plus verteporfin (10 μM) (46 ± 11 pA, in the control n = 8, versus 128 ± 19 pA, in the presence of GAL-021 n = 8, p < 0.05). The current trace suppressed by the presence of GAL seen in GH3 cells was, therefore, identified to be an IK(Ca), which was sensitive to attenuation by verteporfin or ionomycin, but not by diazoxide.

3.3. Modification of GAL-021 on the Activity of BKCa Channels in GH3 Cells

Because IK(Ca) is a large and noisy, K+ current which is sensitive to intracellular Ca2+ and membrane depolarization, and it results predominantly from the opening of BKCa channels that have been previously described [36,40]. Therefore, to determine whether the inhibitory effect of GAL-021 on IK(Ca) is linked to the perturbations on the unitary amplitude, the channel open-state probability, or both, the activity of BKCa channels present in these cells was measured and analyzed. As shown in Figure 3, under high-K+ conditions, the activity of BKCa channels can be readily observed in an excised inside-out patch. When the detached patch was exposed to GAL-021, the activity of channel openings was progressively decreased (Figure 3). The open-state probability of the channel measured at the level of +60 mV under control condition (i.e., in the absence of GAL-021) was found to be 0.182 ± 0.012 (n = 8). We found out that the addition of GAL-021 (10 μM) to the bath medium decreased the channel activity to 0.022 ± 0.002 (n = 8 and p < 0.01). However, there was no significant difference in the amplitude of the unitary outward current between the absence and presence of GAL-021 (11.4 ± 0.9 pA in the control versus 11.2 ± 0.8 pA in the presence of GAL-021, n = 8 and p > 0.05). Further addition of cilostazol (10 μM), still in the presence of GAL-021 (10 μM), was effective at reversing GAL-021-mediated suppression of BKCa-channel activity, while that of 9-phenanthrol (10 μM) had minimal effects on it. Cilostazol or 9-phenanthrol have been known to stimulate the activity of BKCa channels or intermediate-conductance Ca2+-activated K+ (IKCa) channels, respectively [40,41,42]. Therefore, it is apparent that the presence of GAL-021 can decrease the opening probability of BKCa channels in these cells, but not that of IKCa channels.

3.4. Effect of GAL-021 on Kinetic Behavior of BKCa Channels

We further analyzed the effect of GAL-021 on the gating kinetics of these channels because of its inability to modify single-channel amplitude. In excised patches of control cells, open- or closed-time histograms at the level of +60 mV can be fitted with the goodness of fits by a one or two-exponential curve, respectively (Figure 4). The time constant for the open-time histogram was estimated to be 2.12 ± 0.11 msec, whereas those for the fast and slow components of the closed-time histogram were 11.4 ± 0.8 and 56.3 ± 2.1 msec, respectively (n = 7). The BKCa channels identified could exist in at least two resting or closed states. Notably, in detached patches, the addition of GAL-021 (3 μM) to the bath did not result in any modification on mean open time of the channel (2.09 ± 0.11 msec, n = 7 and p > 0.05), while it did increase the mean closed time to 24.3 ± 1.9 and 98.2 ± 2.5 ms (n = 7 and p < 0.05). Therefore, these results showed that this compound produced a conceivable increase in channel closed time. Such changes can help to account for its blocking effect on BKCa channels observed in GH3 cells.

3.5. Failure of GAL-021 to Alter Single-Channel Conductance of BKCa Channels

It was further examined whether GAL-021 affects the single-channel conductance of BKCa channels obtained under voltage-clamp conditions. To construct the plots of current amplitude as a function of membrane potential, we applied the voltage ramp pulses from 0 to +120 mV with a duration of 1 sec at a rate of 0.1 Hz to the inside-out patches. Figure 5A depicts the unitary amplitude versus membrane potential (I-V) relationships of BKCa channels with or without the addition of GAL-021 (3 μM). The single-channel conductance (i.e., unitary amplitude divided by membrane potential) of BKCa channels achieved from the linear I-V relationship in control (i.e., in the absence of GAL-021) was 165 ± 7 pS (n = 11) with a reversal potential of 0 ± 1 mV (n = 11). The value was not found to differ significantly from that (164 ± 6 pS, n = 11 and p > 0.05) measured in the presence of GAL-021 (3 μM). As such, GAL-021 produced no significant change in the single-channel conductance of BKCa channels, but it indeed suppressed the channel activity in these cells, together with a prolongation in mean closed time of the channel.

3.6. Effect of GAL-021 on the Activation Curve of BKCa Channels

Figure 5B illustrates the activation curve of BKCa channels taken from the absence or presence of GAL-021 (3 μM). In this set of experiments, the activation curves of the channels were obtained with the aid of the voltage ramp protocol. During the single-channel current recordings, the linear ramp pulses were delivered from +20 to +120 mV with a duration of 1 sec. The plots of the relative open probability as a function of membrane potential applied were constructed and then fitted with a modified Boltzmann function as elaborated under the Materials and Methods section. In control, V1/2 = 66.8 ± 2.3 mV and q = 4.3 ± 0.2 e (n = 7), whereas in the presence of GAL-021 (3 μM), V1/2 = 79.3 ± 2.6 mV and q = 4.1 ± 0.2 e (n = 7). Consequently, the presence of GAL-021 (3 μM) caused a 45% decrease in the maximal open probability of BKCa channels and also resulted in a shift of +13 mV in the voltage dependence of the activation curve of the channels. However, there was no measurable effect on the gating charge (i.e., q) of the curve occurring during the exposure to GAL-021. The present observations, thus, led us to indicate that GAL-021 could suppress the activity of these BKCa channels in a voltage-dependent fashion in GH3 cells.

3.7. Inhibition of M-type K+ Current (IK(M)) in GH3 Cells Produced by GAL-021

In the next set of experiments, we tested if GAL-021 could have any effects on another type of K+ current, namely IK(M), stated presently in these cells [25,43]. To enhance the degree of IK(M), we bathed cells in high-K+ solution and filled up the pipette by using K+-containing solution. As shown in Figure 6, the addition of GAL-021 (10 μM) resulted in a significant reduction of IK(M) amplitude in these cells. Further application of 10 μM flupirtine, but in continued presence of GAL-021, was observed to attenuate GAL-021-induced decrease of IK(M). Similarly, the addition of XE991 or dexmedetomidine to the bath effectively suppressed the amplitude of IK(M) elicited by 1 sec long membrane depolarization from a holding potential of −50 mV to −10 mV (Figure 6). Flupirtine or XE991 was reported to stimulate or suppress neuronal KCNQ currents, respectively, while dexmedetomidine could have anesthetic-sparing effects and has been previously demonstrated to suppress K+ channels [44,45,46,47]. As a result, the data suggested that GAL-021 at a concentration greater than 10 μM could suppress IK(M) in GH3 cells.

3.8. Effect of GAL-021 on Delayed-Rectifier K+ Current (IK(DR)) in GH3 Cells

We further examined whether GAL-021 can perturb another type of K+ currents, namely IK(DR), enriched in these cells [36]. In these experiments, we bathed cells in Ca2+-free, Tyrode’s solution containing 1 μM tetrododoxin and 0.5 mM CdCl2. Tetrododoxin or CdCl2 was used to block voltage-gated Na+ or Ca2+ currents, respectively. Within 2 min of exposing cells to 10 μM GAL-021, the IK(DR) amplitude was mildly suppressed (Figure 7). For example, as the examined cells were depolarized from −50 to +50 mV, the addition of GAL-021 at a concentration of 10 μM decreased IK(DR) amplitude by 22 ± 3% from 847 ± 42 to 663 ± 35 pA (n = 7, and p < 0.05). Thus, these findings reflect that the presence of GAL-021 mildly suppresses the amplitude of IK(DR) in GH3 cells. However, previous studies have demonstrated that the IK(DR) present in GH3 cells could be mediated by several different subtypes of Kv channels, namely Kv1.2, Kv1.4, Kv1.5, Kv2.1, Kv2.2, Kv3.2, Kv4.1, and Kv5.1 [48]. To what extent the GAL-021 action on IK(DR) is specific for a unique subset of delayed-rectifier K+ channels still remains to be studied further.

3.9. Effect of GAL-021 on Erg-Mediated K+ Current (IK(erg)) in GH3 Cells

We further tested the possible perturbations of GAL-021 on another type of voltage-activated K+ current, namely IK(erg) [49], inherently in GH3 cells. To amplify the magnitude of IK(erg), we bathed cells in high-K+, Ca2+-free solution. However, as shown in Figure 8, we were unable to detect any perturbation by this compound on the peak components of deactivating IK(erg) measured at the different levels of membrane potential. For example, at the level of −120 mV, no noticeable modification in the peak amplitude of deactivating IK(erg) in response to 1 sec membrane hyperpolarization from −10 mV was demonstrated in the presence of 10 μM GAL-021 (498 ± 27 pA in the control versus 49 9 ± 26 pA in the presence of 10 μM GAL-021, n = 8 and p > 0.05). However, further application of telmisartan (10 μM), still in the presence of 10 μM GAL-021, was able to suppress IK(erg) amplitude effectively, as evidenced by a significant reduction of IK(erg) to 249 ± 21 pA (n = 7 and p < 0.05). Telmisartan has previously been demonstrated to suppress IK(erg) identified in heart cells [50]. Therefore, as compared to its inhibitory effect on IK(Ca), the IK(erg) enriched in GH3 cells became relatively resistant to be suppression by GAL-021.

3.10. Effect of GAL-021 on Hyperpolarization-Activated Cationic Current (Ih) Recorded from GH3 Cells

Another set of experiments was done to test if GAL-021 could have any influence on Ih identified in these cells [29,30,31,43]. To record Ih during membrane hyperpolarization, cells were bathed in Ca2+-free, Tyrode’s solution and the recording pipette was filled with K+-containing solution. As illustrated in Figure 9, the application of 30 μM GAL-021 was observed to be effective at suppressing Ih amplitude measured at the entire voltage-clamp steps. The activation time course of Ih in response to long-lasting membrane hyperpolarization concomitantly became slowed in the presence of GAL-021. For example, upon membrane hyperpolarization from −40 to −120 mV with a duration of 2 sec, the GAL-021 (30 μM) addition decreased current amplitude from 263 ± 23 to 77 ± 15 pA (n = 8 and P < 0.05). After washout of the compound, current amplitude returned to 212 ± 21 pA (n = 8 and P < 0.05), which implies that the amplitude partially returned to the control level, due possibly to unknown “run-down” process of the current. Likewise, as cells were exposed to GAL-021 (30 μM), the whole-cell conductance of Ih measured at the voltages ranging between −100 and −120 mV was evidently decreased to 2.81 ± 0.09 nS from a control value of 6.35 ± 0.87 nS (n = 8 and p < 0.05). In keeping with these data, during the exposure to 30 μM GAL-021, the activation time constant of Ih during membrane hyperpolarization was raised from 478 ± 25 to 696 ± 37 ms (n = 8 and p < 0.05).

3.11. Inhibitory Effect of GAL-021 on the Activity of BKCa Channels Expressed in HEK293T Cells Transfected with α-hSlo

In a final set of current recordings, we also wanted to test whether GAL-021 exerts any effects on BKCa-channel activity in HEK293T cells in which α-hSlo was transfected. Under our experimental conditions, the α-hSlo transfection into HEK293T cells resulted in the appearance of BKCa channels. Under inside-out recordings, as GAL-021 was applied to the bath, the probability of BKCa-channel openings was drastically reduced (Figure 10). GAL-021 at a concentration of 30 μM evidently decreased open-state probability of the channel from 0.185 ± 0.012 to 0.009 ± 0.002 (n = 8 and p < 0.01). Subsequent addition of BMS-191011 (10 μM), still in the presence of 30 μM GAL-021, was effective in reversing channel activity suppressed by GAL-021, as evidenced by a significant elevation of channel activity to 0.132 ± 0.011 (n = 6 and p < 0.05) by further application of BMS-191011. BMS-191011 has been reported to be an activator of BKCa channels [20]. As such, in keeping with results from the experiments observed in GH3 cells, the data strongly suggested that the presence of GAL-021 was capable of suppressing BKCa channels that would be open in HEK293T cells expressing α-hSlo.

4. Discussion

The principal findings of this study are as follows: First, in pituitary GH3 lactotrophs, the presence of GAL-021 directly inhibits depolarization-elicited IK(Ca) amplitude in a concentration-dependent manner; second, the inhibitory effect of GAL-021 on the open-state probability of BKCa channels occurs in a voltage-dependent manner; third, there is a lengthening in mean closed time of these channels in its presence, albeit no change in mean open time of the channel; fourth, GAL-021 has minimal noticeable effect on IK(erg) amplitude, however, it mildly suppresses IK(M); fifth, GAL-021 at a concentration greater than 30 μM suppressed the amplitude of Ih; and sixth, GAL-021 suppresses the probabilities of BKCa-channel openings in α-hSlo-expressing HEK-293T cells. Collectively, the present observations led us to propose that the effects on various types of membrane ionic currents presented herein could be one of the ionic mechanisms underlying GAL-021-induced actions, if similar in vivo findings occur in different types of electrically excitable cells (e.g., pituitary cells).
GAL-021-mediated suppression of IK(Ca) observed in GH3 cells was found to be attenuated by further application of either verteporfin or ionomycin, yet not by diazoxide, an activator of KATP channels [51]. Vertiporfin was recently reported to activate BKCa channels [35], while ionomycin is a Ca2+ ionophore. In keeping with the present observations and previous studies [5,6], the inside-out current recordings revealed the effectiveness of GAL-021 in decreasing the open-state probability of BKCa channels that would be open. The inhibitory effect of GAL-021 on such channels is conceivably due to the result of its direct binding to the inner surface of the channel. Moreover, the addition of GAL-021 was able to reduce the open-state probability of BKCa channels in α-hSlo-expressing HEK293T cells. The GAL-021-induced decrease of IK(Ca) described in this study is, therefore, unlikely to be implicated to its suppressive action on KATP or IKCa channels, even though those channels are functionally active in endocrine cells like GH3 cells [24,38]. It is also tempting to speculate that GAL-021 has a unique structure to interact functionally with μ-subunit of the BKCa channel (i.e., KCNMA1 channel) to decrease the amplitude of IK(Ca) observed in GH3 cells.
In this study, the decrease by GAL-021 in the probabilities of BKCa-channel openings recorded from GH3 cells is not attributed to a decrease in single-channel amplitude, because unitary conductance of the channel taken between the absence and presence of GAL-021 apparently failed to differ. A conceivable lengthening in mean closed time (i.e., fast and slow components) of the channels without modification in mean open time could, however, help to account largely for GAL-021-mediated suppression of channel activity. In this scenario, the presence of GAL-021 can prolong the dwelling time of these channels residing in the closed state, along with no profound increase in the duration of individual openings. Moreover, the present observations showed that the presence of GAL-021 resulted in an evident shift of the activation curve of BKCa channels along the voltage axis to more depolarized potentials, despite no change in the gating charge for such activation, that is, there is no dramatic effect of GAL-021 on the steepness of the channel activation curve. In this regard, the valence of a moving charge was not reduced, nor was profile of the local field, through which other charged residues move, changed. It is also reasonable to propose that this compound can functionally interact with BKCa channels in a voltage-dependent manner and its inhibitory actions on these channels would be expected to rely on different conditions, such as the pre-existent resting potential, the concentration of GAL-021 applied, or both, assuming that the GAL-021 action in vivo is similar to those in GH3 cells shown here.
GAL-021-mediated suppression of BKCa-channel activity could arise from various patterns of channel kinetic behaviors. Its inability to alter single-channel conductance of the channel seen in GH3 cells prompts us to indicate that the site(s) of its interaction mainly residing within central pore cavity of the channel are unlikely. However, under inside-out current recordings, in its presence, the fast and slow components in mean closed time of the channel were significantly prolonged, with no clear modification on mean open time. The GAL-021 presence most likely diminishes channel activity by gaining access to its pertinent binding on channel gating. As such, findings from the present results tend to regard GAL-021 as a BKCa inhibitor characterized by a greater affinity for the channel preferentially in the closed state.
GAL-021 treatment is noted to have a short duration of action after a bolus injection [1,52]. The major effect of GAL-021 on ionic currents (e.g., IK(Ca) or IK(M)) shown here also had a rapid onset of action. The effective IC50 required for its suppression of IK(Ca) was 2.33 μM, a value that is clinically achievable [6]. Collectively, the above-given results informed us of the notion that the ion channels (i.e., BKCa [KCNMA1] and M-type [KCNQx] K+ channels) would be a relevant therapeutic target for the pharmacological actions of this drug concurring in vivo, although the detailed mechanism of its actions on ion channels remains to be further resolved.

Author Contributions

Conceptualization, S.-N.W.; methodology, software, and validation, and formal analysis, Z.-H.G., S.-W.L. and T.-L.L.; investigation, S.-N.W.; resources, T.-L.L.; investigation, S.-N.W.; resources, T.-L.L.; data curation, S.-N.W.; writing—original draft preparation, S.-N.W.; writing—review and editing, T.-L.L.; visualization, T.-L.L.; supervision, S.-N.W.; project administration, S.-N.W.; funding acquisition, S.-N.W. and T.-L.L. All authors have read and agreed to the published version of the manuscript.

Funding

The research work detailed in this paper is partly supported by grants from the National Cheng Kung University (D107-F2519, D108-F2507, and NCKUH-10709001), from the Ministry of Science and Technology (MOST-108-2314-B-006-094), and from China Medical University (CMU101-ASIA-07), Taiwan, all of which are through a contract awarded to S.N. Wu.

Acknowledgments

The authors are grateful to Kaisen Lee for technical assistance in earlier work.

Conflicts of Interest

The authors declare that they have no potential conflict of interest that could be perceived as prejudicing the impartiality of the research presented herein.

References

  1. Golder, F.J.; Dax, S.; Baby, S.M.; Gruber, R.; Hoshi, T.; Ideo, C.; Kennedy, A.; Peng, S.; Puskovic, V.; Richie, D.; et al. Identification and characterization of GAL-021 as a novel breathing control modulator. Anesthesiology 2015, 123, 1093–1104. [Google Scholar] [CrossRef] [PubMed]
  2. Golder, F.J.; Hewitt, M.M.; McLeod, J.F. Respiratory stimulant drugs in the post-operative setting. Respir. Physiol. Neurobiol. 2013, 189, 395–402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Cotten, J.F. The latest pharmacologic ventilator. Anesthesiology 2014, 121, 442–444. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. van der Schier, R.; Roozekrans, M.; van Velzen, M.; Dahan, A.; Niesters, M. Opioid-induced respiratory depression: Reversal by non-opioid drugs. F1000Prime Rep. 2014, 6, 79. [Google Scholar] [CrossRef] [PubMed]
  5. Roozekrans, M.; van der Schrier, R.; Okkerse, P.; Hay, J.; McLeod, J.F.; Dahan, A. Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers. Anesthesiology 2014, 121, 459–468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Roozekrans, M.; Olofsen, E.; van der Schrier, R.; van Gerven, J.; Peng, S.; McLeod, J.; Dahan, A. Reversal of opiod-induced respiratory depression by BK-channel blocker GAL-021: A pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Clin. Pharmacol. Ther. 2015, 97, 641–649. [Google Scholar] [CrossRef]
  7. Dahan, A.; van der Schrier, R.; Smith, T.; Aarts, L.; van Velzen, M.; Niesters, M. Averting opioid-induced respiratory depression without affecting analgesia. Anesthesiology 2018, 128, 1027–1037. [Google Scholar] [CrossRef]
  8. McLeod, J.F.; Leempoels, J.M.; Peng, S.X.; Dax, S.L.; Myers, L.J.; Golder, F.J. GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers. Br. J. Anaesth. 2014, 113, 875–883. [Google Scholar] [CrossRef] [Green Version]
  9. Dallas, M.L.; Peers, C.; Golder, F.J.; Baby, S.; Gruber, R.; MacIntyre, D.E. GAL-021 and GAL-160 are efficacious in rat models of obstructive and central sleep apnea and inhibit BKCa in isolated carotid body glomus cells. Adv. Exp. Med. Biol. 2015, 860, 361–370. [Google Scholar]
  10. Peers, C. Effect of lowered extracellular pH on Ca2+-dependent K+ currents in type I cells from the neonatal rat carotid body. J. Physiol. 1990, 422, 381–395. [Google Scholar] [CrossRef]
  11. Riesco-Fagundo, A.M.; Perez-Garcia, M.T.; Gonzalez, C.; Lopez-Lopez, J.R. O2 modulates large-conductance, Ca2+-dependent K+ channels of rat chemoreceptor cells by a membrane restricted and CO-sensitive mechanism. Circ. Res. 2001, 89, 430–436. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Sheu, S.J.; Wu, S.N. Mechanisms of inhibitory actions of oxidizing agents on calcium-activated potassium current in cultured pigment epithelial cells of the human retina. Investig. Ophthalmol. Vis. Sci. 2003, 44, 1237–1244. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Wu, S.N.; Chen, B.S.; Hsu, C.L.; Peng, H. The large-conductance Ca2+-activated K+ channel: A target for the modulators of estrogen receptors. Curr. Top. Biochem. Res. 2008, 10, 93–101. [Google Scholar]
  14. Lo, Y.C.; Tseng, Y.T.; Liu, C.M.; Wu, B.N.; Wu, S.N. Actions of KMUP-1, a xanthine and piperazine derivative on voltage-gated Na+ and Ca2+-activated K+ currents in GH3 pituitary tumour cells. Br. J. Pharmacol. 2015, 172, 5110–5122. [Google Scholar] [CrossRef] [PubMed]
  15. Wang, Y.J.; Chan, M.H.; Chen, L.; Wu, S.N.; Chen, H.H. Resveratrol attenuates cortical neuron activity: Roles of large conductance calcium-activated potassium channels and voltage-gate sodium channels. J. Biomed. Sci. 2016, 23, 47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Wu, S.N.; Chern, J.H.; Shen, S.; Chen, H.H.; Hsu, Y.T.; Lee, C.C.; Chan, M.H.; Lai, M.C.; Shie, F.S. Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels. J. Cell. Physiol. 2017, 232, 3409–3421. [Google Scholar] [CrossRef]
  17. So, E.C.; Wang, Y.; Yang, L.Q.; So, K.H.; Lo, Y.C.; Wu, S.N. Multiple regulatory actions of 2-guanidine-4-methylquinazoline (GMQ), an agonist of acid-sensing ion channel type 3, on ionic currents in pituitary GH3 cells and in olfactory sensory (Rolf B1.T) neurons. Biochem. Pharmacol. 2018, 151, 79–88. [Google Scholar] [CrossRef]
  18. Li, L.; Li, S.; Hu, C.; Zhou, L.; Zhang, Y.; Wang, M.; Qi, Z. BKCa channel is a molecular target of vitamin C to protect against ischemic brain stroke. Mol. Membr. Biol. 2019, 35, 9–20. [Google Scholar] [CrossRef] [Green Version]
  19. Liu, Y.W.; Fang, Y.H.; Su, C.T.; Hwang, S.M.; Liu, P.Y.; Wu, S.N. The biochemical and electrophysiological profiles of amniotic fluid-derived stem cells following Wnt signaling modulation cardiac differentiation. Cell Death Discov. 2019, 5, 1–11. [Google Scholar] [CrossRef]
  20. Hewawasam, P.; Ding, M.; Chen, N.; King, D.; Knipe, J.; Pajor, L.; Ortiz, A.; Gribkoff, V.K.; Starrett, J. Synthesis of water-soluble prodrugs of BMS-191011: A maxi-K channel opener targeted for post-stroke neuroprotection. Bioorg. Med. Chem. Lett. 2003, 13, 1695–1698. [Google Scholar] [CrossRef]
  21. Schrøder, R.L.; Strøbaek, D.; Olesen, S.P.; Christophersen, P. Voltage-independent KCNQ4 currents induced by (+/−) BMS-204352. Pflügers Archiv. 2003, 446, 607–616. [Google Scholar] [CrossRef] [PubMed]
  22. Selyanko, A.A.; Hadley, J.K.; Wood, I.C.; Abogadie, E.C.; Delmas, P.; Buckley, N.J.; London, B.; Brown, D.A. Two types of K+ channel subunit, Erg1 and KCNQ2/3 contribute to the M-like current in a mammalian neuronal cell. J. Neurosci. 1999, 19, 7742–7756. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Greene, D.L.; Hoshi, N. Modulation of Kv7 channels and excitability in the brain. Cell. Mol. Life Sci. 2017, 74, 495–508. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Chen, P.C.; Ruan, J.S.; Wu, S.N. Evidence of decreased activity in intermediate-conductance calcium-activated potassium channels during retinoic acid-induced differentiation in motor neuron-like NSC-34 cells. Cell. Physiol. Biochem. 2018, 48, 2374–2388. [Google Scholar] [CrossRef] [PubMed]
  25. Liu, Y.Y.; Hsiao, H.T.; Wang, J.C.; Liu, Y.C.; Wu, S.N. Parecoxib, a selective blocker of cyclooxygenase-2, directs inhibits neuronal delayed-rectifier K+ current M-type K+ current and Na+ current. Eur. J. Pharmacol. 2018, 844, 95–101. [Google Scholar] [CrossRef] [PubMed]
  26. Pena, F.; Alavez-Perez, N. Epileptiform activity induced by pharmacologic reduction of M-current in the developing hippocampus in vitro. Epilepsia 2006, 47, 47–54. [Google Scholar] [CrossRef] [PubMed]
  27. Du, X.; Gao, H.; Jaffe, D.; Zhang, H.; Gamper, N. M-type K+ channels in peripheral nociceptive pathways. Br. J. Pharmacol. 2018, 175, 2158–2172. [Google Scholar] [CrossRef] [Green Version]
  28. Irisawa, H.; Brown, H.F.; Giles, W. Cardiac pacemaking in the sinoatrial node. Physiol. Rev. 1993, 73, 197–227. [Google Scholar] [CrossRef]
  29. Simasko, S.M.; Sankaranarayanan, S. Characterization of a hyperpolarization-activated cation current in rat pituitary cells. Am. J. Physiol. 1997, 272, E405–E414. [Google Scholar] [CrossRef]
  30. Liu, Y.C.; Wang, Y.J.; Wu, P.Y.; Wu, S.N. Tramadol-induced block of hyperpolarization-activated cation current in rat pituitary lactotrophs. Naunyn Schmiedebergs Arch. Pharmacol. 2009, 379, 127–135. [Google Scholar] [CrossRef]
  31. Hsiao, H.T.; Liu, Y.C.; Liu, P.Y.; Wu, S.N. Concerted suppression of Ih and activation of IK(M) by ivabradine, an HCN-channel inhibitor, in pituitary cells and hippocampal neurons. Brain Res. Bull. 2019, 149, 11–20. [Google Scholar] [CrossRef] [PubMed]
  32. Thoby-Brisson, M.; Cauli, B.; Champagnat, J.; Fortin, G.; Katz, D.M. Expression of functional tyrosine kinase B receptors by rhythmically active respiratory neurons in the pre-Bötzinger complex of neonatal mice. J. Neurosci. 2003, 23, 7685–7689. [Google Scholar] [CrossRef] [PubMed]
  33. Hawkins, V.E.; Hawryluk, J.M.; Takakura, A.C.; Tzingounis, A.V.; Moreira, T.S.; Mulkey, D.K. HCN channels contribute to serotonergic modulation of ventral surface chemosensitive neurons and respiratory activity. J. Neurophysiol. 2015, 113, 1195–1205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Fehsenfeld, S.; Weihrauch, D. The role of an ancestral hyperpolarization-activated cyclic nucleotide-gated K+ channel in branchial acid-base regulation in the green crab, Carcinus maenas. J. Exp. Biol. 2016, 219, 887–896. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Huang, M.H.; Liu, P.Y.; Wu, S.N. Characterization of perturbing actions by verteporfin, a benzoporphyrin photosensitizer, on membrane ionic currents. Front. Chem. 2019, 7, 566. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Wu, S.N.; Hwang, T.; Teng, C.M.; Li, H.F.; Jan, C.R. The mechanism of actions of 3-(5′-(hydroxymethyl-2′-furyl)-1-benzyl indazole (YC-1) on Ca2+-activated K+ currents in GH3 lactotrophs. Neuropharmacology 2000, 39, 1788–1799. [Google Scholar] [CrossRef]
  37. Gribkoff, V.K.; Lum-Ragan, J.T.; Boissard, C.G.; Post-Munson, D.J.; Meanwell, N.A.; Starrett, J.E., Jr.; Kozlowski, E.S.; Romine, J.L.; Trojnacki, J.T.; Mckay, M.C.; et al. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels. Mol. Pharmacol. 1996, 50, 206–217. [Google Scholar]
  38. Wu, S.N.; Li, H.F.; Chiang, H.T. Characterization of ATP-sensitive potassium channels functionally expressed in pituitary GH3 cells. J. Membr. Biol. 2000, 178, 205–214. [Google Scholar] [CrossRef]
  39. Wu, S.N.; Yu, H.S.; Seyama, Y. Analytical studies of spontaneous and vasopressin-induced calcium oscillations in cultured vascular smooth muscle cells. J. Biochem. 1996, 119, 42–48. [Google Scholar] [CrossRef]
  40. Wu, S.N.; Liu, S.I.; Huang, M.H. Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC-12 cells. Endocrinology 2004, 145, 1175–1184. [Google Scholar] [CrossRef] [Green Version]
  41. Wu, S.N.; Chen, H.Z.; Chou, Y.H.; Huang, Y.M.; Lo, Y.C. Inhibitory actions by ibandronate sodium, a nitrogen-containing bisphosphonate, on calcium-activated potassium channels in Madin-Darby canine kidney cells. Toxicol. Rep. 2015, 2, 1182–1193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Yeh, P.S.; Wu, S.J.; Hung, T.Y.; Huang, Y.M.; Hsu, C.W.; Sze, C.I.; Hsieh, Y.J.; Huang, C.W.; Wu, S.N. Evidence for the inhibition by temozolomide, an imidazotetrazine family alkylator, of intermediate-conductance Ca2+-activated K+ channels in glioma cells. Cell. Physiol. Biochem. 2016, 38, 1727–1742. [Google Scholar] [CrossRef] [PubMed]
  43. Lu, T.L.; Chang, W.T.; Chan, C.H.; Wu, S.N. Evidence for effective multiple K+-current inhibitions by tolvaptan, a non-peptide antagonist of vasopressin V2 receptor. Front. Pharmacol. 2019, 10, 76. [Google Scholar] [CrossRef] [PubMed]
  44. Passmore, G.M.; Selyanko, A.A.; Mistry, M.; Al-Qatari, M.; Marsh, S.J.; Matthews, E.A.; Dickenson, A.H.; Brown, T.A.; Burbidge, S.A.; Main, M.; et al. KCNQ/M currents in sensory neurons: Significance for pain therapy. J. Neurosci. 2003, 23, 7227–7236. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Wu, S.N.; Hsu, M.C.; Liao, Y.K.; Wu, F.T.; Jong, Y.J.; Lo, Y.C. Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier K+ currents in motor neuron-like cells. Evid. Based Complement. Altern. Med. 2012, 2012, 10. [Google Scholar] [CrossRef] [Green Version]
  46. Weinbroum, A.A.; Ben-Abraham, R. Dextromethorphan and dexmedetomidine: New agents for the control of perioperative pain. Eur. J. Surg. 2001, 167, 563–569. [Google Scholar]
  47. Chen, B.S.; Peng, H.; Wu, S.N. Dexmedetomidine, an α2-adrenergic agonist, inhibits neuronal delayed-rectifier potassium current and sodium current. Br. J. Anaesth. 2009, 103, 244–254. [Google Scholar] [CrossRef] [Green Version]
  48. Wulfsen, I.; Hauber, H.P.; Schiemann, D.; Bauer, C.K.; Schwarz, J.R. Expression of mRNA for voltage-dependent and inward-rectifying K channels in GH3/B6 cells and rat pituitary. J. Neuroendocrinol. 2000, 12, 263–272. [Google Scholar] [CrossRef]
  49. Wu, S.N.; Jan, C.R.; Li, H.F.; Chiang, H.T. Characterization of inhibition by risperidone of the inwardly rectifying K+ current in pituitary GH3 cells. Neuropsychopharmacology 2000, 23, 676–689. [Google Scholar] [CrossRef]
  50. Chang, W.T.; Wu, S.N. Activation of voltage-gated sodium current and inhibition of erg-mediated potassium current caused by telmisartan, an antagonist of angiotensin II type-1 receptor, in HL-1 atrial cardiomyocytes. Clin. Exp. Pharmacol. Physiol. 2018, 45, 797–807. [Google Scholar] [CrossRef]
  51. Lin, M.W.; Wu, A.Z.; Ting, W.H.; Li, C.L.; Cheng, K.S.; Wu, S.N. Changes in membrane cholesterol of pituitary tumor (GH3) cells regulate the activity of large-conductance Ca2+-activated K+ channels. Chin. J. Physiol. 2006, 49, 1–13. [Google Scholar] [PubMed]
  52. Algera, M.H.; Kamp, J.; van der Schrier, R.; van Velzen, M.; Niesters, M.; Aarts, L.; Dahan, A.; Olofsen, E. Opioid-induced respiratory depression in humans: A review of pharmacokinetic-pharmacodynamic modelling of reversal. Br. J. Anaesth. 2019, 122, e168–e179. [Google Scholar] [CrossRef] [PubMed]
Biomolecules 10 00188 g001 550
Figure 1. Suppressive effects of GAL-021 on the magnitude of Ca2+-activated K+ current (IK(Ca)) recorded from GH3 pituitary tumor cells. In this set of whole-cell current recordings, we immersed cells in normal Tyrode’s solution containing 1.8 mM CaCl2, and the recording pipette used was filled with a K+-containing solution. Current traces are illustrated under voltage-clamp conditions during voltage pulses from 0 to +80 mV in 10-mV increments from a holding potential of 0 mV. (A) Superimposed IK(Ca) traces elicited during a series of voltage steps (indicated in the uppermost part) obtained under control conditions (upper panel), that is, when GAL-021 was not present, and during cell exposure to 1 μM GAL-021 (middle panel) or 3 μM GAL-021 (lower panel). Arrowhead in each panel depicts the zero-current level, whereas calibration mark in the right lower corner applies to all current traces illustrated. (B) Averaged current-voltage (I-V) relationships of IK(Ca) obtained in the control, during the exposure to 1 or 3 μM GAL-021, and after the washout of GAL-021. Each data point represents the mean ± SEM (n = 7 to 9). (C) Concentration-response relationship for GAL-021-mediated suppression of IK(Ca) amplitude (mean ± SEM and n = 8 to 10 for each data point). Each cell was depolarized by 300 ms long voltage step from a holding potential of 0 mV to +50 mV, and current amplitudes at the end of each depolarizing step with or without addition of different GAL-021 concentrations (0.1 to 30 μM) were measured. Continuous line in which data points were overwritten shows least-squares fit of the Hill equation (detailed in the text). The estimated values for IC50 and the Hill coefficient were 2.33 μM and 1.2, respectively.
Figure 1. Suppressive effects of GAL-021 on the magnitude of Ca2+-activated K+ current (IK(Ca)) recorded from GH3 pituitary tumor cells. In this set of whole-cell current recordings, we immersed cells in normal Tyrode’s solution containing 1.8 mM CaCl2, and the recording pipette used was filled with a K+-containing solution. Current traces are illustrated under voltage-clamp conditions during voltage pulses from 0 to +80 mV in 10-mV increments from a holding potential of 0 mV. (A) Superimposed IK(Ca) traces elicited during a series of voltage steps (indicated in the uppermost part) obtained under control conditions (upper panel), that is, when GAL-021 was not present, and during cell exposure to 1 μM GAL-021 (middle panel) or 3 μM GAL-021 (lower panel). Arrowhead in each panel depicts the zero-current level, whereas calibration mark in the right lower corner applies to all current traces illustrated. (B) Averaged current-voltage (I-V) relationships of IK(Ca) obtained in the control, during the exposure to 1 or 3 μM GAL-021, and after the washout of GAL-021. Each data point represents the mean ± SEM (n = 7 to 9). (C) Concentration-response relationship for GAL-021-mediated suppression of IK(Ca) amplitude (mean ± SEM and n = 8 to 10 for each data point). Each cell was depolarized by 300 ms long voltage step from a holding potential of 0 mV to +50 mV, and current amplitudes at the end of each depolarizing step with or without addition of different GAL-021 concentrations (0.1 to 30 μM) were measured. Continuous line in which data points were overwritten shows least-squares fit of the Hill equation (detailed in the text). The estimated values for IC50 and the Hill coefficient were 2.33 μM and 1.2, respectively.
Biomolecules 10 00188 g001
Biomolecules 10 00188 g002 550
Figure 2. (A) Comparisons of effects of GAL-021, GAL-021 plus diazoxide, GAL-021 plus verteporfin, and GAL-021 plus ionomycin on IK(Ca) amplitude recorded from GH3 cells. During these measurements, current amplitude was taken at the end of 300 ms voltage step from a holding potential of 0 mV to +50 mV. Current traces labeled 1 in (A) are controls, and those labeled 2 were taken during cell exposure to 3 μM GAL-021, while those labeled 3 were obtained in the presence of 3 μM GAL-021 plus 10 μM diazoxide (upper panel), or in the presence of 3 μM GAL-021 plus 10 μM verteporfin (lower panel). The uppermost part indicates the voltage protocol applied, arrowhead in each panel shows the zero-current level, and calibration mark in the right lower part in (A) applies to all current traces. (B) Summary bar graph showing effects of GAL-021, GAL-021 plus diazoxide, GAL-021 plus verteporfin, and GAL-021 plus ionomycin on IK(Ca) amplitude. Current amplitudes were recorded and then measured at the end of each depolarizing pulse from 0 to +50 mV, and each bar represents the mean ± SEM (n = 7 to 9). *, Significantly different from control (p < 0.05) and †, significantly different from GAL (3 μM) alone group (p < 0.05). GAL, 3 μM GAL-021; Diaz, 10 μM diazoxide; VP, 10 μM verteporfin; and Iono, 10 μM ionomycin.
Figure 2. (A) Comparisons of effects of GAL-021, GAL-021 plus diazoxide, GAL-021 plus verteporfin, and GAL-021 plus ionomycin on IK(Ca) amplitude recorded from GH3 cells. During these measurements, current amplitude was taken at the end of 300 ms voltage step from a holding potential of 0 mV to +50 mV. Current traces labeled 1 in (A) are controls, and those labeled 2 were taken during cell exposure to 3 μM GAL-021, while those labeled 3 were obtained in the presence of 3 μM GAL-021 plus 10 μM diazoxide (upper panel), or in the presence of 3 μM GAL-021 plus 10 μM verteporfin (lower panel). The uppermost part indicates the voltage protocol applied, arrowhead in each panel shows the zero-current level, and calibration mark in the right lower part in (A) applies to all current traces. (B) Summary bar graph showing effects of GAL-021, GAL-021 plus diazoxide, GAL-021 plus verteporfin, and GAL-021 plus ionomycin on IK(Ca) amplitude. Current amplitudes were recorded and then measured at the end of each depolarizing pulse from 0 to +50 mV, and each bar represents the mean ± SEM (n = 7 to 9). *, Significantly different from control (p < 0.05) and †, significantly different from GAL (3 μM) alone group (p < 0.05). GAL, 3 μM GAL-021; Diaz, 10 μM diazoxide; VP, 10 μM verteporfin; and Iono, 10 μM ionomycin.
Biomolecules 10 00188 g002
Biomolecules 10 00188 g003a 550Biomolecules 10 00188 g003b 550
Figure 3. Suppressive effect of GAL-021 on the activity of BKCa channels identified in GH3 cells. In these experiments, cells were immersed in high K+ solution containing 0.1 μM Ca2+, inside-out current recordings were performed, and channel activity was measured at the level of +60 mV. The upper or lower part in (A) shows original channel current traces or the probability of channel openings, respectively. Horizontal bar indicates the addition of 10 μM GAL-021 into the bath. The left (control) or right (during the exposure to GAL-021) current traces in the lowest part of (A) corresponds to the expanded records from dashed boxes in the upper part. Channel-opening event is denoted as an upward deflection (i.e., outward current). Of note, there is a progressive decrease in the channel open probability during the exposure to GAL-021 (10 μM). (B) Summary bar graph showing effect of GAL-021, GAL-021 plus cilostazol, and GAL-021 plus 9-phenanthrol on the probability of BKCa-channel openings (mean ± SEM and n = 6 to 8 for each bar). Inside-out current recordings were taken and the open-state probability of the channel was measured at +60 mV. * Significantly different from control (p < 0.05); **, significantly different from control (p < 0.01); † significantly different from GAL-021 (3 μM) alone group (p < 0.05); and ‡, significantly different from GAL-021 (10 μM) alone group (p < 0.05). Cil, 10 μM cilostazol and GAL, GAL-021.
Figure 3. Suppressive effect of GAL-021 on the activity of BKCa channels identified in GH3 cells. In these experiments, cells were immersed in high K+ solution containing 0.1 μM Ca2+, inside-out current recordings were performed, and channel activity was measured at the level of +60 mV. The upper or lower part in (A) shows original channel current traces or the probability of channel openings, respectively. Horizontal bar indicates the addition of 10 μM GAL-021 into the bath. The left (control) or right (during the exposure to GAL-021) current traces in the lowest part of (A) corresponds to the expanded records from dashed boxes in the upper part. Channel-opening event is denoted as an upward deflection (i.e., outward current). Of note, there is a progressive decrease in the channel open probability during the exposure to GAL-021 (10 μM). (B) Summary bar graph showing effect of GAL-021, GAL-021 plus cilostazol, and GAL-021 plus 9-phenanthrol on the probability of BKCa-channel openings (mean ± SEM and n = 6 to 8 for each bar). Inside-out current recordings were taken and the open-state probability of the channel was measured at +60 mV. * Significantly different from control (p < 0.05); **, significantly different from control (p < 0.01); † significantly different from GAL-021 (3 μM) alone group (p < 0.05); and ‡, significantly different from GAL-021 (10 μM) alone group (p < 0.05). Cil, 10 μM cilostazol and GAL, GAL-021.
Biomolecules 10 00188 g003aBiomolecules 10 00188 g003b
Biomolecules 10 00188 g004 550
Figure 4. Effect of GAL-021 on mean open (A) and closed (B) times of BKCa channels in GH3 cells. Inside-out current recordings were made in these experiments and the potential was maintained at +60 mV. Cells were immersed in high-K+ solution which contained 0.l μM Ca2+. The open- and closed-time histograms under control conditions (i.e., GAL-021 is not present) are illustrated in the left side of each panel, while those acquired during the exposure to 3 μM GAL-021 are in the right side. Of note, the abscissa and ordinate in each panel show the scale of apparent open- or closed-time histograms (msec, in a logarithmic scale) and the square root of the event numbers ( n ), respectively. Control data were acquired from measurements of 361 channel openings with a total record time of 1 min, whereas those taken in the presence of GAL-021 were taken from 333 channel openings with a total recording time of 2 min. Nonlinear continuous line in each histogram was least-squares fitted by single- or two-exponential function, while the broken line(s) in each lifetime distribution are pointed at the values of the time constants in open or closed state(s). Of note, the fast and slow components in mean closed time of the channel became prolonged in the presence of 3 μM GAL-021, despite its inability to modify mean open time.
Figure 4. Effect of GAL-021 on mean open (A) and closed (B) times of BKCa channels in GH3 cells. Inside-out current recordings were made in these experiments and the potential was maintained at +60 mV. Cells were immersed in high-K+ solution which contained 0.l μM Ca2+. The open- and closed-time histograms under control conditions (i.e., GAL-021 is not present) are illustrated in the left side of each panel, while those acquired during the exposure to 3 μM GAL-021 are in the right side. Of note, the abscissa and ordinate in each panel show the scale of apparent open- or closed-time histograms (msec, in a logarithmic scale) and the square root of the event numbers ( n ), respectively. Control data were acquired from measurements of 361 channel openings with a total record time of 1 min, whereas those taken in the presence of GAL-021 were taken from 333 channel openings with a total recording time of 2 min. Nonlinear continuous line in each histogram was least-squares fitted by single- or two-exponential function, while the broken line(s) in each lifetime distribution are pointed at the values of the time constants in open or closed state(s). Of note, the fast and slow components in mean closed time of the channel became prolonged in the presence of 3 μM GAL-021, despite its inability to modify mean open time.
Biomolecules 10 00188 g004
Biomolecules 10 00188 g005a 550Biomolecules 10 00188 g005b 550
Figure 5. The voltage-dependent effect of GAL-021 on the activity of BKCa channels identified in GH3 cells. The experiments were conducted with symmetrical K+ concentration, and we filled the electrode with K+-containing solution. Under inside-out current recordings, the potential was maintained at +60 mV and bath medium contained 0.1 μM Ca2+. (A) Failure of GAL-021 to modify the single-channel conductance of BKCa channels. The voltage ramp pulses from 0 to +120 mV with a duration of 1 sec were used to measure single-channel conductance taken with or without GAL-021 addition. The straight broken line with a reversal potential of 0 mV represents the I-V relations of the channels in the absence (upper) or presence (lower) of GAL-021 (3 μM). (B) Effect of GAL-021 on the sigmoid activation kinetics of BKCa channels. The currents illustrated were activated by applying the upsloping ramp pulses from +20 to +120 mV with a duration of 1 sec. The continuous lines showed Boltzmann fits of the data yielding 66.8 mV for the control (i.e., GAL-021 was not present) and 79.3 mV obtained as the detached patch was exposed to 3 μM GAL-021.
Figure 5. The voltage-dependent effect of GAL-021 on the activity of BKCa channels identified in GH3 cells. The experiments were conducted with symmetrical K+ concentration, and we filled the electrode with K+-containing solution. Under inside-out current recordings, the potential was maintained at +60 mV and bath medium contained 0.1 μM Ca2+. (A) Failure of GAL-021 to modify the single-channel conductance of BKCa channels. The voltage ramp pulses from 0 to +120 mV with a duration of 1 sec were used to measure single-channel conductance taken with or without GAL-021 addition. The straight broken line with a reversal potential of 0 mV represents the I-V relations of the channels in the absence (upper) or presence (lower) of GAL-021 (3 μM). (B) Effect of GAL-021 on the sigmoid activation kinetics of BKCa channels. The currents illustrated were activated by applying the upsloping ramp pulses from +20 to +120 mV with a duration of 1 sec. The continuous lines showed Boltzmann fits of the data yielding 66.8 mV for the control (i.e., GAL-021 was not present) and 79.3 mV obtained as the detached patch was exposed to 3 μM GAL-021.
Biomolecules 10 00188 g005aBiomolecules 10 00188 g005b
Biomolecules 10 00188 g006 550
Figure 6. Inhibition by GAL-021 of M-type K+ current (IK(M)) in GH3 cells. In this set of experiments, to amplify the current magnitude, cells were immersed in high-K+, Ca2+-free solution, the examined cell was maintained at −50 mV and, once whole-cell recordings were achieved, the 1 sec long step depolarization to −10 mV was applied. (A) Superimposed IK(M) traces recorded in the control (a), and during the exposure to 10 μM GAL-021 (b), or to 10 μM GAL-021 plus 10 μM flupirtine (c). (B) Summary bar graph showing effects of GAL-021, XE991, dexmedetomidine, and GAL-021 plus flupirtine on IK(M) amplitude (mean ± SEM and n = 6–9 for each bar). Current amplitudes were measured at the end of each depolarizing command pulse from a holding potential of −50 mV to −10 mV. DEX, 10 μM dexmedetomidine; Flu, 10 μM flupirtine; and GAL, 10 μM GAL-021. *, Significantly different from control (p < 0.05) and †significantly different from GAL-021 (10 μM) alone group (p < 0.05). (C) Concentration-response curve for the GAL-021-induced suppression of IK(M) (mean ± SEM and n = 6 to 8 for each data point). The smooth sigmoidal curve was fitted with the Hill equation (detailed under Materials and Methods). The IC50 value was computed to be 3.75 μM and the Hill coefficient was 1.1.
Figure 6. Inhibition by GAL-021 of M-type K+ current (IK(M)) in GH3 cells. In this set of experiments, to amplify the current magnitude, cells were immersed in high-K+, Ca2+-free solution, the examined cell was maintained at −50 mV and, once whole-cell recordings were achieved, the 1 sec long step depolarization to −10 mV was applied. (A) Superimposed IK(M) traces recorded in the control (a), and during the exposure to 10 μM GAL-021 (b), or to 10 μM GAL-021 plus 10 μM flupirtine (c). (B) Summary bar graph showing effects of GAL-021, XE991, dexmedetomidine, and GAL-021 plus flupirtine on IK(M) amplitude (mean ± SEM and n = 6–9 for each bar). Current amplitudes were measured at the end of each depolarizing command pulse from a holding potential of −50 mV to −10 mV. DEX, 10 μM dexmedetomidine; Flu, 10 μM flupirtine; and GAL, 10 μM GAL-021. *, Significantly different from control (p < 0.05) and †significantly different from GAL-021 (10 μM) alone group (p < 0.05). (C) Concentration-response curve for the GAL-021-induced suppression of IK(M) (mean ± SEM and n = 6 to 8 for each data point). The smooth sigmoidal curve was fitted with the Hill equation (detailed under Materials and Methods). The IC50 value was computed to be 3.75 μM and the Hill coefficient was 1.1.
Biomolecules 10 00188 g006
Biomolecules 10 00188 g007 550
Figure 7. Mild inhibitory effect of GAL-021 on delayed-rectifier K+ current (IK(DR)) in GH3 cells. In these experiments, we bathed cells in Ca2+-free, Tyrode’s solution which contained 1 μM tetrodotoxin and 0.5 mM CdCl2. The holding potential was −50 mV and clamp pulses to a series of voltage steps ranging between –50 and +50 mV with a duration of 1 sec (as indicated in the uppermost part of (A) were applied. (A) Representative IK(DR) traces recorded in the absence (upper) and presence (lower) of 10 μM GAL-021. (B) Averaged I-V relationships of IK(DR) obtained in the control (■) and during cell exposure to 10 μM GAL-021 (□). Current amplitude was measured at the end of each voltage step, and each data point represents the mean ± SEM (n = 7). Of note, GAL-021 at a concentration of 10 μM mildly suppresses IK(DR) amplitude.
Figure 7. Mild inhibitory effect of GAL-021 on delayed-rectifier K+ current (IK(DR)) in GH3 cells. In these experiments, we bathed cells in Ca2+-free, Tyrode’s solution which contained 1 μM tetrodotoxin and 0.5 mM CdCl2. The holding potential was −50 mV and clamp pulses to a series of voltage steps ranging between –50 and +50 mV with a duration of 1 sec (as indicated in the uppermost part of (A) were applied. (A) Representative IK(DR) traces recorded in the absence (upper) and presence (lower) of 10 μM GAL-021. (B) Averaged I-V relationships of IK(DR) obtained in the control (■) and during cell exposure to 10 μM GAL-021 (□). Current amplitude was measured at the end of each voltage step, and each data point represents the mean ± SEM (n = 7). Of note, GAL-021 at a concentration of 10 μM mildly suppresses IK(DR) amplitude.
Biomolecules 10 00188 g007
Biomolecules 10 00188 g008 550
Figure 8. Inability of GAL-021 to suppress erg-mediated K+ current (IK(erg)) obtained in GH3 cells. We bathed cells in high-K+, Ca2+-free solution and the pipette used was filled with K+-containing solution. (A) Superimposed IK(erg) traces in the control (upper) and during the exposure to 10 μM GAL-021 (lower). The IK(erg) was activated by a series of long-step voltage pulse indicated in the uppermost part of (A). (B) Averaged I-V relationship of deactivating IK(erg) in the absence and presence of GAL-021 (10 μM) or GAL-021 (10 μM) plus telmisartan (Tel, 10 μM). Current amplitude was measured at the beginning of each hyperpolarizing voltage step. Each data point represents the mean ± SEM (n = 7 to 8). Note that GAL at a concentration of 10 μM was unable to suppress IK(erg) in these cells.
Figure 8. Inability of GAL-021 to suppress erg-mediated K+ current (IK(erg)) obtained in GH3 cells. We bathed cells in high-K+, Ca2+-free solution and the pipette used was filled with K+-containing solution. (A) Superimposed IK(erg) traces in the control (upper) and during the exposure to 10 μM GAL-021 (lower). The IK(erg) was activated by a series of long-step voltage pulse indicated in the uppermost part of (A). (B) Averaged I-V relationship of deactivating IK(erg) in the absence and presence of GAL-021 (10 μM) or GAL-021 (10 μM) plus telmisartan (Tel, 10 μM). Current amplitude was measured at the beginning of each hyperpolarizing voltage step. Each data point represents the mean ± SEM (n = 7 to 8). Note that GAL at a concentration of 10 μM was unable to suppress IK(erg) in these cells.
Biomolecules 10 00188 g008
Biomolecules 10 00188 g009a 550Biomolecules 10 00188 g009b 550
Figure 9. Inhibitory effect of GAL-021 on hyperpolarization-activated cationic current (Ih) identified in GH3 cells. In these whole-cell current recordings, cells were bathed in Ca2+-free, Tyrode’s solution, and the recording pipette was filled with K+-containing solution. (A) Representative Ih traces obtained in the absence (upper) or presence (lower) of 30 μM GAL-021. The uppermost part indicates the voltage-clamp protocol applied. (B) Averaged I-V relationships of Ih amplitude obtained in the control (i.e., in the absence of GAL-021), during the exposure to 30 μM GAL-021 and washout of GAL-021 (mean ± SEM and n = 8 for each data point). Current amplitude was collected at the end of 2 sec hyperpolarizing potential.
Figure 9. Inhibitory effect of GAL-021 on hyperpolarization-activated cationic current (Ih) identified in GH3 cells. In these whole-cell current recordings, cells were bathed in Ca2+-free, Tyrode’s solution, and the recording pipette was filled with K+-containing solution. (A) Representative Ih traces obtained in the absence (upper) or presence (lower) of 30 μM GAL-021. The uppermost part indicates the voltage-clamp protocol applied. (B) Averaged I-V relationships of Ih amplitude obtained in the control (i.e., in the absence of GAL-021), during the exposure to 30 μM GAL-021 and washout of GAL-021 (mean ± SEM and n = 8 for each data point). Current amplitude was collected at the end of 2 sec hyperpolarizing potential.
Biomolecules 10 00188 g009aBiomolecules 10 00188 g009b
Biomolecules 10 00188 g010 550
Figure 10. Effect of GAL-021 on BKCa-channel activity in α-hSlo-expressing HEK293T cells. Cells were suspended in high-K+ solution containing 0.1 μM Ca2+, and inside-out current recordings were made at the holding potential of +60 mV. (A) Representative BKCa-channel currents obtained in the control (left) and after bath application of 30 μM GAL-021 (right). (B) Summary bar graph depicting effect of GAL-021 (10 or 30 μM) and GAL-021 (30 μM) plus BMS-191011 (10 μM) on the open-state probability of BKCa (or KCNMA1) channels (mean ± SEM and n = 6 to 8 for each bar). *, Significantly different from control or GAL-021 (10 μM) alone group (p < 0.05); **, significantly different from control (p < 0.01); and †, significantly different from GAL-021 (30 μM) alone group (p < 0.05).
Figure 10. Effect of GAL-021 on BKCa-channel activity in α-hSlo-expressing HEK293T cells. Cells were suspended in high-K+ solution containing 0.1 μM Ca2+, and inside-out current recordings were made at the holding potential of +60 mV. (A) Representative BKCa-channel currents obtained in the control (left) and after bath application of 30 μM GAL-021 (right). (B) Summary bar graph depicting effect of GAL-021 (10 or 30 μM) and GAL-021 (30 μM) plus BMS-191011 (10 μM) on the open-state probability of BKCa (or KCNMA1) channels (mean ± SEM and n = 6 to 8 for each bar). *, Significantly different from control or GAL-021 (10 μM) alone group (p < 0.05); **, significantly different from control (p < 0.01); and †, significantly different from GAL-021 (30 μM) alone group (p < 0.05).
Biomolecules 10 00188 g010

Share and Cite

MDPI and ACS Style

Lu, T.-L.; Gao, Z.-H.; Li, S.-W.; Wu, S.-N. High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BKCa-Channel Activity and Inhibits IK(M) or Ih. Biomolecules 2020, 10, 188. https://doi.org/10.3390/biom10020188

AMA Style

Lu T-L, Gao Z-H, Li S-W, Wu S-N. High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BKCa-Channel Activity and Inhibits IK(M) or Ih. Biomolecules. 2020; 10(2):188. https://doi.org/10.3390/biom10020188

Chicago/Turabian Style

Lu, Te-Ling, Zi-Han Gao, Shih-Wei Li, and Sheng-Nan Wu. 2020. "High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BKCa-Channel Activity and Inhibits IK(M) or Ih" Biomolecules 10, no. 2: 188. https://doi.org/10.3390/biom10020188

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop